StockpollyBeta
Get App
Delisting riskPopularity #4,794
CLDI · AMEX · Biotechnology

Calidi Biotherapeutics (CLDI)

Develops systemic oncolytic-virus platforms that deliver therapeutic payloads into tumors.

$1.06
After hours−0.03 (−2.76%)
At close$1.09(−1.80%)

In millions of USD, except per-share figures

In millionsQ4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Cost of revenue00000000000
Gross profit00000000000
96654565444
Research & development43222232233
54432333222
Selling & marketing00000000000
General & administrative64430333222
Other expenses00000000000
Operating income−10−7−6−5−4−5−6−5−4−4−4
20000000000
Interest expense00000000000
Other non-operating income−20000000000
Income before tax−8−7−6−5−4−5−6−5−4−4−4
Income tax expense00000000000
Net income from continuing operations−8−7−6−5−4−5−6−5−4−4−4
Other adjustments00000000000
Net income−8−7−6−5−4−5−6−5−4−4−4
EPS, basic−$444.80−$390.72−$268.80−$124.80−$37.89−$35.36−$31.84−$35.36−$8.96−$6.88−$2.94
EPS, diluted−$444.80−$390.72−$268.80−$124.80−$37.89−$35.36−$31.84−$35.36−$8.96−$6.88−$2.94
Weighted average shares, basic00000000011
Weighted average shares, diluted00000000011
EBITDA−8−7−5−4−4−5−5−5−4−4−4
Depreciation & amortization00000000000
EBIT−8−7−5−5−4−5−6−5−4−4−4